Alligator Bioscience AB (publ) (STO:ATORX)
3.900
-0.100 (-2.50%)
May 21, 2025, 5:29 PM CET
Alligator Bioscience AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -179.49 | -233.89 | -248.59 | -193.4 | -141.74 | -143.3 | Upgrade
|
Depreciation & Amortization | 8.48 | 9.88 | 10.43 | 11.31 | 12.31 | 11.39 | Upgrade
|
Other Amortization | 0.02 | 0.02 | 0.06 | 0.13 | 0.13 | 0.13 | Upgrade
|
Asset Writedown & Restructuring Costs | 38.83 | 38.83 | - | 0.32 | -1.3 | - | Upgrade
|
Stock-Based Compensation | 0.04 | 0.06 | 0.07 | 0.1 | 0 | 0.04 | Upgrade
|
Other Operating Activities | -45.52 | 2.07 | 1 | -0.05 | - | -1.13 | Upgrade
|
Change in Accounts Receivable | 2.47 | 4.95 | 13.27 | -5.86 | -13.59 | 2.12 | Upgrade
|
Change in Other Net Operating Assets | -11.27 | -34.34 | 34.47 | 14.84 | 17.14 | -10.61 | Upgrade
|
Operating Cash Flow | -186.43 | -212.43 | -189.29 | -172.61 | -127.03 | -141.35 | Upgrade
|
Capital Expenditures | -1.46 | - | -2.46 | -0.44 | -0.05 | -0.1 | Upgrade
|
Sale of Property, Plant & Equipment | 3.67 | - | - | - | - | - | Upgrade
|
Investment in Securities | - | - | - | - | - | 156.99 | Upgrade
|
Investing Cash Flow | 2.21 | - | -2.46 | -0.44 | -0.05 | 156.89 | Upgrade
|
Long-Term Debt Issued | - | 135 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -8.29 | -9.75 | -7.91 | -6.97 | -6.15 | Upgrade
|
Net Debt Issued (Repaid) | -30.05 | 126.71 | -9.75 | -7.91 | -6.97 | -6.15 | Upgrade
|
Issuance of Common Stock | 250.79 | 98.88 | 195.54 | 0.38 | 342.67 | - | Upgrade
|
Repurchase of Common Stock | - | - | - | -0.38 | - | - | Upgrade
|
Other Financing Activities | -46.16 | -14.33 | -24.22 | 0.08 | -33.9 | - | Upgrade
|
Financing Cash Flow | 174.58 | 211.27 | 161.56 | -7.83 | 301.8 | -6.15 | Upgrade
|
Foreign Exchange Rate Adjustments | -1.53 | -0.65 | -1 | 0.03 | 0.06 | 0.15 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
Net Cash Flow | -11.17 | -1.81 | -31.19 | -180.84 | 174.78 | 9.53 | Upgrade
|
Free Cash Flow | -187.89 | -212.43 | -191.74 | -173.05 | -127.08 | -141.45 | Upgrade
|
Free Cash Flow Margin | -368.41% | -368.01% | -323.61% | -480.67% | -953.54% | -2564.90% | Upgrade
|
Free Cash Flow Per Share | -76.61 | -289.30 | -427.53 | -784.49 | -1417.17 | -1981.45 | Upgrade
|
Cash Interest Paid | 12.15 | 4.04 | 0.48 | 0.65 | 0.24 | 0.35 | Upgrade
|
Levered Free Cash Flow | -141.11 | -39.34 | -100.16 | -98.69 | -74.03 | -87.3 | Upgrade
|
Unlevered Free Cash Flow | -122.45 | -27.03 | -99.86 | -98.29 | -73.89 | -87.1 | Upgrade
|
Change in Net Working Capital | -3.8 | -105.84 | -47.91 | -10.8 | -2.24 | 8.54 | Upgrade
|
Updated Jan 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.